Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature

J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1420-e1422. doi: 10.1111/jdv.19346. Epub 2023 Jul 20.

Aurore Dupont^{1

2}, Rémi Vergara³, Alizé Pacaud^{1

2}, Laure Dequidt^{1

2}, Caroline Dutriaux^{1

2}, Valentine Saunier⁴, Charline Caumont^{5

6}, Marie-Laure Jullie³, Alain Taïeb^{1

2

6}, Fanny Morice-Picard^{1

2

6}, Léa Dousset^{1

2

6}

¹ Department of Dermatology and Pediatric Dermatology, Hospital of Bordeaux, Bordeaux, France.
² National Reference Center for Rare Skin Disorders, Hospital of Bordeaux, Bordeaux, France.
³ Department of Pathology, Hospital of Bordeaux, Pessac, France.
⁴ Department of Ophthalmology, Hospital of Bordeaux, Bordeaux, France.
⁵ Laboratory of Tumor Biology and Tumor Biobank, Hospital of Bordeaux, Pessac, France.
⁶ INSERM U1312, TRIO2, University of Bordeaux, Bordeaux, France.

No abstract available

Publication types